$DBD
DIEBOLD NIXDORF, Inc Stock $dbd

$dbd Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000002882321000081 Filed on May 10, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2020 Q1
Revenue	$943.5M	$943.9M	$910.7M
YoY Change	5.95%	3.65%	-11.42%
Cost Of Revenue	$691.6M	$670.7M	$683.9M
YoY Change	7.58%	-1.93%	-12.54%
Gross Profit	$251.9M	$273.2M	$226.8M
YoY Change	1.74%	20.46%	-7.84%
Gross Profit Margin	26.7%	28.94%	24.9%
Selling, General & Admin	$204.8M	$203.4M	$222.1M
YoY Change	12.78%	-8.42%	-3.56%
% of Gross Profit	81.3%	74.45%	97.93%
Research & Development	$35.60M	$34.10M	$32.50M
YoY Change	15.96%	4.92%	-11.92%
% of Gross Profit	14.13%	12.48%	14.33%
Depreciation & Amortization	$38.60M	$19.80M	$26.50M
YoY Change	-27.17%	-25.28%	-54.62%
% of Gross Profit	15.32%	7.25%	11.68%
Operating Expenses	$239.0M	$237.0M	$252.8M
YoY Change	5.24%	-6.25%	-6.58%
Operating Profit	$12.90M	$36.20M	-$26.00M
YoY Change	-37.07%	-239.23%	6.12%
Interest Expense	$49.70M	$48.70M	$48.00M
YoY Change	2.9%	1.46%	-5.7%
% of Operating Profit	385.27%	134.53%
Other Income/Expense, Net	-$53.90M	-$42.00M	-$47.40M
YoY Change	14.68%	-11.39%	1.72%
Pretax Income	-$41.00M	-$5.800M	-$73.40M
YoY Change	54.72%	-92.1%	3.23%
Income Tax	-$11.20M	$1.200M	$20.00M
% Of Pretax Income
Net Earnings	-$30.30M	-$8.100M	-$92.80M
YoY Change	27.85%	-91.27%	-30.07%
Net Earnings / Revenue	-3.21%	-0.86%	-10.19%
Basic Earnings Per Share		-$0.10
Diluted Earnings Per Share	-$387.0K	-$103.8K	-$1.202M
COMMON SHARES
Basic Shares Outstanding	78.23M shares	78.00M shares	77.53M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q2	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$232.4M	$256.1M	$522.0M
YoY Change	-48.56%	-50.94%	65.24%
Cash & Equivalents	$224.3M	$234.8M	$512.1M
Short-Term Investments	$8.100M	$21.30M	$13.50M
Other Short-Term Assets	$249.6M	$246.6M	$253.1M
YoY Change	0.36%	-2.57%	-17.37%
Inventory	$587.5M	$538.7M	$475.5M
Prepaid Expenses	$48.90M	$58.60M	$44.10M
Receivables	$638.6M	$629.1M	$594.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.816B	$1.793B	$2.045B
YoY Change	-4.17%	-12.34%	-4.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$154.3M	$156.7M	$216.1M
YoY Change	-24.91%	-27.49%	-26.62%
Goodwill	$779.1M	$771.4M	$736.2M
YoY Change	0.52%	4.78%	-9.51%
Intangibles	$396.1M	$410.7M	$467.5M
YoY Change	-12.77%	-12.15%	-20.6%
Long-Term Investments	$10.60M	$10.40M	$18.10M
YoY Change	-39.08%	-42.54%	35.07%
Other Assets	$316.4M	$314.8M	$285.6M
YoY Change	11.72%	10.22%	208.09%
Total Long-Term Assets	$1.719B	$1.723B	$1.793B
YoY Change	-5.86%	-3.94%	-18.11%
TOTAL ASSETS
Total Short-Term Assets	$1.816B	$1.793B	$2.045B
Total Long-Term Assets	$1.719B	$1.723B	$1.793B
Total Assets	$3.535B	$3.516B	$3.839B
YoY Change	-5.0%	-8.42%	-11.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$561.5M	$546.9M	$499.2M
YoY Change	17.08%	9.56%	1.5%
Accrued Expenses	$211.7M	$201.4M	$170.3M
YoY Change	-1.76%	18.26%	-25.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$32.90M	$11.00M	$103.4M
YoY Change	-68.27%	-89.36%	119.07%
Total Short-Term Liabilities	$1.591B	$1.629B	$1.646B
YoY Change	4.16%	-1.02%	-0.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.319B	$2.271B	$2.353B
YoY Change	-2.0%	-3.51%	7.4%
Other Long-Term Liabilities	$145.6M	$146.7M	$193.7M
YoY Change	-24.52%	-24.26%	112.39%
Total Long-Term Liabilities	$145.6M	$146.7M	$193.7M
YoY Change	-24.52%	-24.26%	112.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.591B	$1.629B	$1.646B
Total Long-Term Liabilities	$145.6M	$146.7M	$193.7M
Total Liabilities	$1.737B	$1.776B	$1.839B
YoY Change	0.94%	-3.47%	5.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$780.7M	-$750.4M	-$565.1M
YoY Change	32.59%	32.79%	87.74%
Common Stock	$932.0M	$927.5M	$893.2M
YoY Change	3.93%	3.84%	1.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$582.1M	$581.9M	$576.5M
YoY Change	0.95%	0.94%	0.87%
Treasury Stock Shares	16.25M shares	16.23M shares	15.83M shares
Shareholders Equity	-$851.3M	-$848.6M	-$727.9M
YoY Change
Total Liabilities & Shareholders Equity	$3.535B	$3.516B	$3.839B
YoY Change	-5.0%	-8.42%	-11.29%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$30.30M	-$8.100M	-$92.80M
YoY Change	27.85%	-91.27%	-30.07%
Depreciation, Depletion And Amortization	$38.60M	$19.80M	$26.50M
YoY Change	-27.17%	-25.28%	-54.62%
Cash From Operating Activities	-$80.00M	-$65.20M	-$78.20M
YoY Change	33.56%	-16.62%	36.95%
INVESTING ACTIVITIES
Capital Expenditures	-$3.700M	-$2.500M	-$5.400M
YoY Change	8.82%	-53.7%	-63.27%
Acquisitions
YoY Change
Other Investing Activities	$17.60M	$5.700M	$3.400M
YoY Change	2414.29%	67.65%	-37.04%
Cash From Investing Activities	$13.90M	$3.200M	-$53.40M
YoY Change	-614.81%	-105.99%	364.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.800M	$5.000M
YoY Change		16.0%	354.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	53.40M	-$24.90M	$314.0M
YoY Change	-775.95%	-107.93%	-2358.99%
NET CHANGE
Cash From Operating Activities	-80.00M	-$65.20M	-$78.20M
Cash From Investing Activities	13.90M	$3.200M	-$53.40M
Cash From Financing Activities	53.40M	-$24.90M	$314.0M
Net Change In Cash	-12.70M	-$88.70M	$166.8M
YoY Change	-81.99%	-153.18%	-300.96%
FREE CASH FLOW
Cash From Operating Activities	-$80.00M	-$65.20M	-$78.20M
Capital Expenditures	-$3.700M	-$2.500M	-$5.400M
Free Cash Flow	-$76.30M	-$62.70M	-$72.80M
YoY Change	35.04%	-13.87%	71.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000028823
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	1-4879
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	Diebold Nixdorf, Incorporated
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-0183970
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5995 Mayfair Road, PO Box 3077,
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	North Canton,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44720-8077
CY2021Q1	dei	City Area Code CityAreaCode	330
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	490-4000
CY2021Q1	dei	Security12b Title Security12bTitle	Common shares, $1.25 par value per share
CY2021Q1	dei	Trading Symbol TradingSymbol	DBD
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78228257	shares
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	234800000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324500000	USD
CY2021Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	21300000	USD
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	37200000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35100000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37500000	USD
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	629100000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	646900000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	538700000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	498200000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58600000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58800000	USD
CY2021Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	63800000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	64700000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	246600000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	227000000.0	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	1792900000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1857300000	USD
CY2021Q1	us-gaap	Long Term Investments LongTermInvestments	10400000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	10300000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	538300000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	536100000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156700000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	177500000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	771400000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	800400000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	99000000.0	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	97500000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	314800000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	306500000	USD
CY2021Q1	us-gaap	Assets Assets	3515600000	USD
CY2020Q4	us-gaap	Assets Assets	3657400000	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	11000000.0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10700000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	546900000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	499900000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	146700000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	152600000	USD
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	19200000	USD
CY2021Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2020Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	365800000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	346800000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	201400000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	226600000	USD
CY2021Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	15400000	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	15400000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	488400000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	550100000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1628900000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1649500000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2270700000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2335700000	USD
CY2021Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	205900000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	228700000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	103400000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	103400000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.25
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.25
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94438989	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93534866	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78209484	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77678984	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	118000000.0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	116900000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	809500000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	787900000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-750400000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-742300000	USD
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	16229505	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	15855882	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	581900000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	576700000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-443800000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-412900000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-848600000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-827100000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	8600000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-4600000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-840000000.0	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-831700000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3515600000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3657400000	USD
CY2021Q1	us-gaap	Revenues Revenues	943900000	USD
CY2020Q1	us-gaap	Revenues Revenues	910700000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	670700000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	683900000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	273200000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	226800000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	203400000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	222100000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34100000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32500000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	500000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1800000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	237000000.0	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	252800000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	36200000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26000000.0	USD
CY2021Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1700000	USD
CY2020Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1100000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	48700000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	48000000.0	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5700000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	400000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-700000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-900000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5800000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73400000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000000.0	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1100000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-8100000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-93400000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-1200000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-600000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78000000.0	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	77200000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.20
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-8100000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-93400000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2100000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-19700000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-4500000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1600000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-15200000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	2600000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	6800000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-900000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30400000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-105500000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-38500000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-198900000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	500000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1900000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39000000.0	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-197000000.0	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-8100000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-93400000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19800000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26500000	USD
CY2021Q1	dbd	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	19900000	USD
CY2020Q1	dbd	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	21400000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	4300000	USD
CY2020Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	5600000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3500000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4000000.0	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	500000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1800000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1800000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	14100000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1300000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8000000.0	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60200000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33900000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	64100000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	47300000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	32200000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	66400000	USD
CY2021Q1	dbd	Increase Decrease In Sales Tax And Net Value Added Tax IncreaseDecreaseInSalesTaxAndNetValueAddedTax	-24500000	USD
CY2020Q1	dbd	Increase Decrease In Sales Tax And Net Value Added Tax IncreaseDecreaseInSalesTaxAndNetValueAddedTax	-20400000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	8500000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-31800000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-18900000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-46400000	USD
CY2021Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-10600000	USD
CY2020Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-4800000	USD
CY2021Q1	dbd	Increase Decrease In Warranty Reserve IncreaseDecreaseInWarrantyReserve	-400000	USD
CY2020Q1	dbd	Increase Decrease In Warranty Reserve IncreaseDecreaseInWarrantyReserve	-3600000	USD
CY2021Q1	dbd	Increasedecreaseinliabilitiesheldforsale Increasedecreaseinliabilitiesheldforsale	0	USD
CY2020Q1	dbd	Increasedecreaseinliabilitiesheldforsale Increasedecreaseinliabilitiesheldforsale	-13100000	USD
CY2021Q1	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-16400000	USD
CY2020Q1	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-11000000.0	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	61400000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	30700000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65200000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-78200000	USD
CY2021Q1	dbd	Payments To Acquire Property Plant And Equipment Including Software PaymentsToAcquirePropertyPlantAndEquipmentIncludingSoftware	2500000	USD
CY2020Q1	dbd	Payments To Acquire Property Plant And Equipment Including Software PaymentsToAcquirePropertyPlantAndEquipmentIncludingSoftware	5400000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5900000	USD
CY2020Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5100000	USD
CY2021Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2020Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-38500000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	109200000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	40100000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	97600000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	44500000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3200000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53400000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3800000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-30000000.0	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	385900000	USD
CY2021Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	600000	USD
CY2020Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	20000000.0	USD
CY2021Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2400000	USD
CY2020Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	83100000	USD
CY2021Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	12700000	USD
CY2020Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5800000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5000000.0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24900000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	314000000.0	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1800000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-15600000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-88700000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	166800000	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	2700000	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	97200000	USD
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	3700000	USD
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	32800000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324500000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280900000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	234800000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	512100000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dbd	Incremental Shares Excluded From Dilutive Calculation Due To Resultingin Operating Loss IncrementalSharesExcludedFromDilutiveCalculationDueToResultinginOperatingLoss	1300000	shares
CY2020Q1	dbd	Incremental Shares Excluded From Dilutive Calculation Due To Resultingin Operating Loss IncrementalSharesExcludedFromDilutiveCalculationDueToResultinginOperatingLoss	3100000	shares
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-8100000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-93400000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-600000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-8100000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-92800000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	78000000.0	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	77200000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.20
CY2021Q1	dbd	Anti Dilutive Shares Not Used In Calculating Diluted Weighted Average Shares AntiDilutiveSharesNotUsedInCalculatingDilutedWeightedAverageShares	1600000	shares
CY2020Q1	dbd	Anti Dilutive Shares Not Used In Calculating Diluted Weighted Average Shares AntiDilutiveSharesNotUsedInCalculatingDilutedWeightedAverageShares	2800000	shares
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.174
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.272
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	212100000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	204700000	USD
CY2021Q1	dbd	Other Inventories Spare Parts Net Of Reserves OtherInventoriesSparePartsNetOfReserves	172700000	USD
CY2020Q4	dbd	Other Inventories Spare Parts Net Of Reserves OtherInventoriesSparePartsNetOfReserves	169000000.0	USD
CY2021Q1	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	153900000	USD
CY2020Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	124500000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	538700000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	498200000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Amount LifeInsuranceCorporateOrBankOwnedAmount	3700000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	15600000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	3800000	USD
CY2021Q1	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	26100000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceived	46700000	USD
CY2020Q4	us-gaap	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceived	44000000.0	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	300000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	200000	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable Due Thereafter CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter	3400000	USD
CY2021Q1	us-gaap	Capital Leases Net Investment In Sales Type Leases Unguaranteed Residual Values Of Leased Property CapitalLeasesNetInvestmentInSalesTypeLeasesUnguaranteedResidualValuesOfLeasedProperty	200000	USD
CY2020Q4	us-gaap	Capital Leases Net Investment In Sales Type Leases Unguaranteed Residual Values Of Leased Property CapitalLeasesNetInvestmentInSalesTypeLeasesUnguaranteedResidualValuesOfLeasedProperty	200000	USD
CY2021Q1	dbd	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received And Unguaranteed Residual Values CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceivedAndUnguaranteedResidualValues	46600000	USD
CY2020Q4	dbd	Capital Leases Net Investment In Sales Type Leases Minimum Payments To Be Received And Unguaranteed Residual Values CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceivedAndUnguaranteedResidualValues	44000000.0	USD
CY2021Q1	dbd	Capital Leases Net Investment In Sales Type Leases Unearned Interest Income CapitalLeasesNetInvestmentInSalesTypeLeasesUnearnedInterestIncome	1400000	USD
CY2020Q4	dbd	Capital Leases Net Investment In Sales Type Leases Unearned Interest Income CapitalLeasesNetInvestmentInSalesTypeLeasesUnearnedInterestIncome	1500000	USD
CY2021Q1	dbd	Capital Leases Net Investment In Sales Type Leases Receivable Net CapitalLeasesNetInvestmentInSalesTypeLeasesReceivableNet	45200000	USD
CY2020Q4	dbd	Capital Leases Net Investment In Sales Type Leases Receivable Net CapitalLeasesNetInvestmentInSalesTypeLeasesReceivableNet	42500000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable Current CapitalLeasesFutureMinimumPaymentsReceivableCurrent	16500000	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable In Two Years CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears	8700000	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable In Three Years CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears	6600000	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable In Four Years CapitalLeasesFutureMinimumPaymentsReceivableInFourYears	6000000.0	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5500000	USD
CY2021Q1	us-gaap	Capital Leases Future Minimum Payments Receivable CapitalLeasesFutureMinimumPaymentsReceivable	46700000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2019Q4	us-gaap	Goodwill Gross GoodwillGross	1234900000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	470900000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	764000000.0	USD
CY2020	us-gaap	Goodwill Transfers GoodwillTransfers	-1400000	USD
CY2020	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	10000000.0	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	47800000	USD
CY2020Q4	us-gaap	Goodwill Gross GoodwillGross	1271300000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	470900000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	800400000	USD
CY2021Q1	us-gaap	Goodwill Transfers GoodwillTransfers	0	USD
CY2021Q1	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	300000	USD
CY2021Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-28700000	USD
CY2021Q1	us-gaap	Goodwill Gross GoodwillGross	1242300000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5100000	USD
CY2021Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	470900000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	771400000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1047700000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	637000000.0	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	410700000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1085900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	637300000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	448600000	USD
CY2021Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5900000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	6000000.0	USD
CY2020Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	7800000	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26100000	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	27600000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	38600000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	36900000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5000000.0	USD
CY2020Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5000000.0	USD
CY2021Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5300000	USD
CY2020Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	8600000	USD
CY2021Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-2100000	USD
CY2020Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-2000000.0	USD
CY2021Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	36200000	USD
CY2020Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	31300000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	6000000.0	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	10000000.0	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	6000000.0	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	10000000.0	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	6000000.0	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	10000000.0	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	62900000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	42600000	USD
CY2021Q1	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2020Q1	us-gaap	Severance Costs1 SeveranceCosts1	10000000.0	USD
CY2021Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	8900000	USD
CY2020Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	15500000	USD
CY2021Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-3100000	USD
CY2020Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	0	USD
CY2021Q1	us-gaap	Restructuring Reserve RestructuringReserve	50900000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	37100000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dbd	Uncommitted Lines Of Credit UncommittedLinesOfCredit	1300000	USD
CY2020Q4	dbd	Uncommitted Lines Of Credit UncommittedLinesOfCredit	200000	USD
CY2021Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	600000	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	11000000.0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10700000	USD
CY2021Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3200000	USD
CY2020Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3100000	USD
CY2021Q1	dbd	Long Term Debt Excluding Debt Issuance Costs LongTermDebtExcludingDebtIssuanceCosts	2320700000	USD
CY2020Q4	dbd	Long Term Debt Excluding Debt Issuance Costs LongTermDebtExcludingDebtIssuanceCosts	2390500000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	50000000.0	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	54800000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2270700000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2335700000	USD
CY2020Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	193800000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	163500000	USD
CY2020Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	177300000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000.0	USD
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	451000000.0	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000000.0	USD
CY2020Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	65100000	USD
CY2021Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2400000	USD
CY2020Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	83100000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	19200000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	20900000	USD
CY2021Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	0	USD
CY2020Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	0	USD
CY2021Q1	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	0	USD
CY2020Q1	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-300000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	19200000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2020Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	20600000	USD
CY2021Q1	dbd	Capital Contributions From Noncontrolling Interests CapitalContributionsFromNoncontrollingInterests	12700000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-831700000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-8100000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30400000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3500000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5200000	USD
CY2021Q1	dbd	Reclassification From Noncontrolling Interests To Redeemable Noncontrolling Interests ReclassificationFromNoncontrollingInterestsToRedeemableNoncontrollingInterests	31900000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-840000000.0	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-506300000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-93400000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-105500000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4000000.0	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4600000	USD
CY2020Q1	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	4800000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-710600000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-412900000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-33000000.0	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2100000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-30900000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-443800000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-375300000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-115500000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-11300000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-104200000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-479500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	1300000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2100000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-11300000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	16100000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	13700000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6100000	USD
CY2020Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-14800000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q3	dbd	Notional Amount Of Derivatives Early Terminated NotionalAmountOfDerivativesEarlyTerminated	625000000.0	USD
CY2021Q1	dbd	Payment For Termination Of Interest Rate Derivative Instruments PaymentForTerminationOfInterestRateDerivativeInstruments	6200000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dbd	Fair Value Transfers Between Levels Amount FairValueTransfersBetweenLevelsAmount	0	USD
CY2020Q1	dbd	Fair Value Transfers Between Levels Amount FairValueTransfersBetweenLevelsAmount	0	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2017Q1	dbd	Shares Repurchased Of Redeemable Noncontrolling Interest SharesRepurchasedOfRedeemableNoncontrollingInterest	6900000	shares
CY2019Q2	dbd	Shares Repurchased Of Redeemable Noncontrolling Interest SharesRepurchasedOfRedeemableNoncontrollingInterest	1400000	shares
CY2021Q1	dbd	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2020Q1	dbd	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	646900000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	346800000	USD
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	629100000	USD
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	365800000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	346800000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dbd	Net Sales NetSales	109.2
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	us-gaap	Revenues Revenues	943900000	USD
CY2020Q1	us-gaap	Revenues Revenues	910700000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	36200000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5800000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73400000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26000000.0	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42000000.0	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-47400000	USD
CY2021Q1	dbd	Non Routine Expenses Net NonRoutineExpensesNet	19900000	USD
CY2021Q1	us-gaap	Revenues Revenues	943900000	USD
CY2020Q1	us-gaap	Revenues Revenues	910700000	USD
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31

Files In Submission

Name	View Source	Status
R26.htm	Edgar Link	pending
0000028823-21-000081-index-headers.html	Edgar Link	pending
0000028823-21-000081-index.html	Edgar Link	pending
0000028823-21-000081.txt	Edgar Link	pending
0000028823-21-000081-xbrl.zip	Edgar Link	pending
dbd-20210331.htm	Edgar Link	pending
dbd-20210331.xsd	Edgar Link	pending
dbd-20210331_cal.xml	Edgar Link	unprocessable
dbd-20210331_def.xml	Edgar Link	unprocessable
dbd-20210331_htm.xml	Edgar Link	completed
dbd-20210331_lab.xml	Edgar Link	unprocessable
dbd-20210331_pre.xml	Edgar Link	unprocessable
dbd3312021ex221.htm	Edgar Link	pending
dbd3312021ex311.htm	Edgar Link	pending
dbd3312021ex312.htm	Edgar Link	pending
dbd3312021ex321.htm	Edgar Link	pending
dbd3312021ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DBD
DIEBOLD NIXDORF, Inc Stock $dbd

2021 Q2 Form 10-Q Financial Statement

#000002882321000081 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DBD DIEBOLD NIXDORF, Inc Stock $dbd

2021 Q2 Form 10-Q Financial Statement

#000002882321000081 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DBD
DIEBOLD NIXDORF, Inc Stock $dbd